eClinicalMedicine in conversation with

Alasdair MacGowan on oral treatments for MRSA skin infections

January 26, 2023 eClinicalMedicine
eClinicalMedicine in conversation with
Alasdair MacGowan on oral treatments for MRSA skin infections
Show Notes

Professor Alasdair MacGowan joins Charlotte Rowbottom, Senior Editor at eClinicalMedicine, to discuss treatment options for skin infections caused by MRSA, antimicrobial stewardship, and their research comparing the safety and efficacy of two therapeutic regimens.

Read the full article:
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled phase 4 trial

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv